Safety Concerns Surround Tesla Inc's (TSLA) Production Rush

Tesla Inc (NASDAQ:TSLA) was able to meet its latest production goal, but a new report has emerged that says the company skipped a step in the testing phase while doing so. The company contends that it did so only because the test was redundant.

CNBC has the details on the latest flap surrounding Tesla.

As it pushed to hit its electric vehicle production targets for the quarter, Tesla decided to skip “brake-and-roll” testing for its Model 3 sedans in its Fremont factory.

The news was first reported by Business Insider.

The company managed to meet a self-imposed deadline to produce 5,000 Model 3 cars in a week after several quarters of missing its goals.

The company explained to CNBC that it recently did away with this specific test. “Every car we build goes through rigorous quality checks and must meet exacting specifications, including brake tests. To be extremely clear, we drive *every* Model 3 on our test track to verify braking, torque, squeal and rattle,” the company said. “There are no exceptions.”

The company also confirmed that all vehicles are tested on-site for brakes and alignment after assembly is completed.

Tesla Inc shares rose $2.72 (+0.87%) in premarket trading Thursday. Year-to-date, TSLA has declined -0.16%, versus a 2.38% rise in the benchmark S&P 500 index during the same period.

TSLA currently has a StockNews.com POWR Rating of B (Buy), and is ranked #4 of 24 stocks in the Auto & Vehicle Manufacturers category.